Quantitative biomarkers for liver metastases: Comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR
Clinical Radiology Jun 06, 2018
Stein D, et al. - Researchers examined the ability of apparent diffusion coefficient (ADC) heterogeneity index to discriminate liver metastases (LM) from normal-appearing liver (NAL) tissue as compared to common magnetic resonance imaging (MRI) metrics, as well as investigated its relationship with 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET) standardised uptake value (SUV). For the purpose of this investigation, thirty-nine liver metastases in 24 oncology patients with proven LM from heterogeneous sources were evaluated on a PET/MRI system. Results of this study suggested that the ADCcv index was a potential biomarker of LM with better correlation to 18F-FDG PET SUVpeak than conventional MRI metrics, and could serve to quantitatively discriminate between LM and NAL.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries